Striking staff not allowed to return to work at Mayo Clinic’s Albert Lea hospital

A day after about 80 employees at Mayo Clinic Health System in Albert Lea, Minnesota, staged a one-day strike, the hospital wouldn’t let them return to work, following through on Mayo’s threats to do so because of one-week contracts with replacement workers.

The striking employees are members of the Service Employees International Union (SEIU) Health Care Minnesota. The union represents certified nursing assistants, housekeepers, skilled maintenance employees, sterile processing and utilities/materials management workers.

According to the Albert Lea Tribune, workers were prevented from entering the building at 6 a.m. on Dec. 20.

“I think it’s a sad day, especially for Mayo, because it does not show that they are—they’re always saying, ‘We’re here for the patient and the people’—well, it shows that they’re not here for the people,” said materials management employee Charlotte Nelson-Shocker.

Mayo had stated any employees participating in the one-day strike on Dec. 19 wouldn’t be allowed to return to work for a week because of commitments needed to hire replacement workers. The health system also disputed using the term “lock out.”

“They made the decision to stop work,” said Mayo Clinic spokesperson Ginger Plumbo. “This is not a lock out.”

Read more on the reasons behind the one-day strike at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.